ACTIVE

GENZYME FLANDERS

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result80,1 M €+36,3 %over 1 year

Revenue457,2 M €+6,7 %over 1 year

Equity862,1 M €+10,2 %over 1 year

Workforce990,1 ETP+12,2 %over 1 year

Identity

Source · BCE/KBO

GENZYME FLANDERS is a Private limited company incorporated in 2001. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Geel. It employs on average 990,1 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0475.955.046
Incorporation: 07/11/2001
Legal form: Private limited company
Registered office: Cipalstraat 8
2440 Geel · FlandreSee on map
Contributed capital: 351 962 500,00 €
Latest accounts: 31/12/2025
Average workforce: 990,1 ETP

Activities (NACE)

21201Manufacture of pharmaceutical preparations· main 21201Manufacture of pharmaceutical preparations 24421Aluminium production

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

Financials

Source · NBB, 22 filings

Trend over 18 financial years

	2025		2024		2023		2022		2021
Income statement
Revenue	457,2 M €	+6.7%	428,6 M €	-0.7%	431,6 M €	+11.9%	385,7 M €	+13.3%	340,5 M €
EBITDA	165,4 M €	+22.1%	135,5 M €	-14.3%	158 M €	+23.0%	128,4 M €	+20.9%	106,2 M €
Operating result	105,2 M €	+39.9%	75,2 M €	-8.5%	82,2 M €	+43.7%	57,2 M €	-1.5%	58 M €
Net result	80,1 M €	+36.3%	58,8 M €	-5.8%	62,4 M €	+44.8%	43,1 M €	-0.9%	43,5 M €
Balance sheet
Equity	862,1 M €	+10.2%	782 M €	+8.1%	723,4 M €	+9.4%	661,1 M €	+7.0%	618 M €
Total assets	1 Md €	+6.7%	939,5 M €	+0.6%	933,7 M €	+9.6%	852,2 M €	+15.8%	736,2 M €
Cash	–		–		–		–		–
Debts	135,5 M €	-10.5%	151,4 M €	-4.6%	158,7 M €	-7.0%	170,6 M €	+52.4%	112 M €
Other
Workforce	990,1 ETP	+12.2%	882,2 ETP	+2.7%	858,7 ETP	-0.5%	862,8 ETP	-1.2%	873,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

more than 1.000 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 20 ended

Active mandates

Wendy Morren

Director · since 01 janvier 2023

Active

Peter Oldenziel

Director · since 30 octobre 2020

Active

Ended mandates

Julien MOINDROT

Director · since 03 novembre 2020

Ended

Julien Moindrot

Director · since 30 octobre 2020 · until 01 janvier 2023

Ended

Julien Moindrot

Director · since 30 octobre 2020

Ended

Esther HEUBERGER

Manager · since 01 octobre 2017

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	24/06/2026	14/07/2025	04/07/2024	13/07/2023	15/07/2022	24/06/2021
General meeting	16/06/2026	20/06/2025	21/06/2024	30/06/2023	30/06/2022	18/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 22 filings

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	16/06/2026	24/06/2026	Dutch	PDF
Full model	31/12/2024	20/06/2025	14/07/2025	Dutch	PDF
Full model	31/12/2023	21/06/2024	04/07/2024	Dutch	PDF
Full model	31/12/2022	30/06/2023	13/07/2023	Dutch	PDF
Full model	31/12/2021	30/06/2022	15/07/2022	Dutch	PDF
Full model	31/12/2020	18/06/2021	24/06/2021	Dutch	PDF
Full model	31/12/2019	19/06/2020	29/06/2020	Dutch	PDF
Full model	31/12/2018	21/06/2019	24/06/2019	Dutch	PDF
Full model	31/12/2017	22/06/2018	22/06/2018	Dutch	PDF
Full modelCorrection	31/12/2016	27/06/2017	24/07/2017	Dutch	PDF
Full model	31/12/2016	27/06/2017	28/06/2017	Dutch	PDF
Full model	31/12/2015	17/06/2016	21/06/2016	Dutch	PDF
Full model	31/12/2014	19/06/2015	22/06/2015	Dutch	PDF
Full modelCorrection	31/12/2013	20/06/2014	04/11/2014	Dutch	PDF
Full model	31/12/2013	20/06/2014	24/06/2014	Dutch	PDF
Full model	31/12/2012	21/06/2013	09/07/2013	Dutch	PDF
Full model	31/12/2011	15/06/2012	28/06/2012	Dutch	PDF
Full model	31/12/2010	24/06/2011	28/06/2011	Dutch	PDF
Full model	31/12/2009	25/06/2010	06/07/2010	Dutch	PDF
Full model	31/12/2008	19/06/2009	29/06/2009	Dutch	PDF
Full model	31/12/2007	20/06/2008	27/06/2008	Dutch	PDF
Full model	31/12/2006	15/06/2007	29/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

more than 1.000 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2024

2 active · 20 ended

Active mandates

Wendy Morren

Director · since 01 janvier 2023

Active

Peter Oldenziel

Director · since 30 octobre 2020

Active

Ended mandates

Julien MOINDROT

Director · since 03 novembre 2020

Ended

Julien Moindrot

Director · since 30 octobre 2020 · until 01 janvier 2023

Ended

Julien Moindrot

Director · since 30 octobre 2020

Ended

Esther HEUBERGER

Manager · since 01 octobre 2017

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates16/06/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/01/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/01/2023
ONTSLAGEN - BENOEMINGEN
PDF
Mandates22/07/2021
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates14/01/2021
ONTSLAGEN - BENOEMINGEN - WIJZIGING RECHTSVORM
PDF
Mandates25/07/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/10/2017
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/03/2017
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202580,1 M €↑
01/05/2025
nominationHao Zheng — bestuurder
2024
Annual accounts 202458,8 M €↓
21/06/2024
nominationKurt Marichal — commissaris
2023
Annual accounts 202362,4 M €↑
01/01/2023
nominationWendy Morren — zaakvoerder
2022
Annual accounts 202243,1 M €↓
2021
Annual accounts 202143,5 M €↑
2020
Annual accounts 202039,2 M €↑
2019
Annual accounts 201921,3 M €↓
2018
Annual accounts 201825,9 M €↑
2017
Annual accounts 20176,9 M €↓
2016
Annual accounts 201629,2 M €↑
2015
Annual accounts 2015-19,6 M €↓
2014
Annual accounts 201420,5 M €↓
2013
Annual accounts 201322,4 M €↑
2012
Annual accounts 201220,4 M €↓
2011
Annual accounts 201121,9 M €↓
2010
Annual accounts 201025,4 M €↓
2009
Annual accounts 200987,8 M €↑
2008
Annual accounts 2008-30,5 M €
07/11/2001
IncorporationPrivate limited company

GENZYME FLANDERS

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline